Kolkata, West Bengal -- (SBWIRE) -- 09/27/2013 -- Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on MannKind Corporation (NASDAQ:MNKD), Dendreon Corporation (NASDAQ:DNDN).
MannKind Corporation (NASDAQ:MNKD) shares gained 1.85% to $6.05. BofA/Merrill downgraded MannKind to Underperform from Neutral on Sept. 6. The firm's physician survey indicates indicates an increased cautious stance following Afrezza Ph. III results for use in Type 2 diabetes patients on oral therapies. The firm lowered its peak share estimate to 2% of the oral market vs. 4% previously. Price target lowered to $5 from $8.
Should Investors Buy MNKD After Yesterday’s Jump? Find Out Here
Dendreon Corporation (NASDAQ:DNDN) shares gained 0.34% to $2.98. The company on Sept. 17 announced that the European Commission (EC) has granted marketing authorization for PROVENGE® (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) dispersion for infusion in the European Union (EU) for the treatment of asymptomatic or minimally symptomatic metastatic (non-visceral) castrate resistant prostate cancer in male adults in whom chemotherapy is not yet clinically indicated. This final decision by the EC follows recent positive opinions from both the European Medicines Agency (EMA) Committee for Advanced Therapy (CAT) and the Committee for Medicinal Products for Human Use (CHMP) recommending that PROVENGE be granted marketing authorization in the EU.
How Should Investors Trade DNDN After The Recent Volatility? Get Free Trend Analysis Here
Specialpennystockalert.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Specialpennystockalert.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at Specialpennystockalert.com.
The assembled information disseminated by Specialpennystockalert.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Specialpennystockalert.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)